BioPharma Dive1 min read
saveChina could ‘corner’ biopharmaceutical sector with new plan, US panel warns
A commission called on U.S. lawmakers to act quickly to prevent an “overdependence” on China that could leave American patients “vulnerable to supply chain weaponization.”
comments(0)
5-min edit window · permanent after that